| Market Capitalization (Millions $) |
21,312 |
| Shares
Outstanding (Millions) |
115 |
| Employees |
13,000 |
| Revenues (TTM) (Millions $) |
5,057 |
| Net Income (TTM) (Millions $) |
1,133 |
| Cash Flow (TTM) (Millions $) |
297 |
| Capital Exp. (TTM) (Millions $) |
145 |
Perkinelmer Inc
We are a leading provider of scientific instruments, consumables and services
to the pharmaceutical, biomedical, environmental testing, chemical and general
industrial markets. We design, manufacture, market and service products and systems
within three businesses, each of which is its own reporting segment:
• Life and Analytical Sciences. We are a leading provider of drug discovery,
genetic screening, and environmental and chemical analysis tools, including
instruments, reagents, consumables and services.
• Optoelectronics. We provide a broad range of digital imaging, sensor and
specialty lighting components used in the biomedical, consumer products and
other specialty end markets.
• Fluid Sciences. We provide critical fluid control and containment systems
for highly demanding environments such as turbine engines and semiconductor
fabrication facilities.
Company Address: 940 Winter Street, Waltham, 2451 MA
Company Phone Number: 663-6900 Stock Exchange / Ticker: NYSE PKI
| PKI is expected to report next financial results on March 01, 2022. |
|
|
0.37% 
60.99 %